{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T13:45:03Z","timestamp":1776865503653,"version":"3.51.2"},"reference-count":70,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background: Breast cancer (BC) is a leading cause of cancer-related mortality worldwide and a major public health concern in Mexico. Regulatory variants in KRAS, particularly within the 3\u2032UTR and intronic regions, may influence gene expression through microRNA binding and transcriptional regulation. Methods: Five regulatory single-nucleotide variants (SNVs) in KRAS (rs12228277, rs1137196, rs8720, rs12587, and rs12245) were genotyped in BC patients and cancer-free controls. Associations were evaluated using odds ratios (ORs) with 95% confidence intervals (CIs), adjusting for age, alcohol, and tobacco use. Multiple testing was corrected using the Benjamini\u2013Hochberg false discovery rate (FDR). Linkage disequilibrium (LD), multilocus combinations, and in silico functional analyses were also performed. Results: Variants rs12228277, rs1137196, rs8720, and rs12245 showed significant genotype-level associations with BC susceptibility, all remaining significant after FDR correction (pFDR &lt; 0.05). No clinicopathological associations remained significant after correction in single-variant analyses. Multilocus analysis identified specific high-risk combinations (e.g., involving rs12228277, rs1137196, and rs8720) associated with increased BC susceptibility. At the nominal level, these combinations showed associations with clinicopathological features, including hormone receptor\u2013positive status (PR and ER), proliferation markers, and Luminal B subtype; however, none remained significant after FDR correction. LD analysis indicated weak linkage among variants. In silico analyses suggested potential regulatory effects on microRNA binding and KRAS expression. Conclusions: Regulatory variants in KRAS are associated with BC susceptibility through independent effects and potential combinatorial patterns. These findings support the relevance of non-coding variation in cancer risk and warrant further functional and replication studies.<\/jats:p>","DOI":"10.3390\/biomedicines14040948","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T12:00:32Z","timestamp":1776859232000},"page":"948","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regulatory Variants in the KRAS 3\u2032UTR and Intron 2 Are Associated with Breast Cancer Susceptibility Through Independent and Combinatorial Effects in a Mexican Population"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9788-1106","authenticated-orcid":false,"given":"Asbiel Felipe","family":"Garibaldi-R\u00edos","sequence":"first","affiliation":[{"name":"Divisi\u00f3n de Gen\u00e9tica, Centro de Investigaci\u00f3n Biom\u00e9dica de Occidente (CIBO), Centro M\u00e9dico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico"},{"name":"Doctorado en Gen\u00e9tica Humana, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Guadalajara 44340, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6096-4579","authenticated-orcid":false,"given":"Luis E.","family":"Figuera","sequence":"additional","affiliation":[{"name":"Divisi\u00f3n de Gen\u00e9tica, Centro de Investigaci\u00f3n Biom\u00e9dica de Occidente (CIBO), Centro M\u00e9dico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico"},{"name":"Doctorado en Gen\u00e9tica Humana, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Guadalajara 44340, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2774-6390","authenticated-orcid":false,"given":"Belinda Claudia","family":"G\u00f3mez-Meda","sequence":"additional","affiliation":[{"name":"Instituto de Gen\u00e9tica Humana \u201cDr. Enrique Corona Rivera\u201d, Departamento de Biolog\u00eda Molecular y Gen\u00f3mica, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Guadalajara 44340, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1257-4637","authenticated-orcid":false,"given":"Guillermo Mois\u00e9s","family":"Z\u00fa\u00f1iga-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Divisi\u00f3n de Medicina Molecular, Centro de Investigaci\u00f3n Biom\u00e9dica de Occidente (CIBO), Centro M\u00e9dico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Sierra Mojada 800, Col. Independencia, Guadalajara 44340, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid Patricia","family":"D\u00e1valos-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Divisi\u00f3n de Gen\u00e9tica, Centro de Investigaci\u00f3n Biom\u00e9dica de Occidente (CIBO), Centro M\u00e9dico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico"},{"name":"Doctorado en Gen\u00e9tica Humana, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Guadalajara 44340, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia Montserrat","family":"Garc\u00eda-Verd\u00edn","sequence":"additional","affiliation":[{"name":"Divisi\u00f3n de Gen\u00e9tica, Centro de Investigaci\u00f3n Biom\u00e9dica de Occidente (CIBO), Centro M\u00e9dico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico"},{"name":"Doctorado en Gen\u00e9tica Humana, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Guadalajara 44340, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda","family":"Puebla-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunofarmacolog\u00eda, Centro Universitario de Ciencias Exactas e Ingenier\u00edas, Universidad de Guadalajara (UdeG), Guadalajara 44430, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9307-0937","authenticated-orcid":false,"given":"Irving Alejandro","family":"Carrillo-D\u00e1vila","sequence":"additional","affiliation":[{"name":"Divisi\u00f3n de Gen\u00e9tica, Centro de Investigaci\u00f3n Biom\u00e9dica de Occidente (CIBO), Centro M\u00e9dico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico"},{"name":"Doctorado en Gen\u00e9tica Humana, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Guadalajara 44340, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4539-1693","authenticated-orcid":false,"given":"Martha Patricia","family":"Gallegos-Arreola","sequence":"additional","affiliation":[{"name":"Divisi\u00f3n de Gen\u00e9tica, Centro de Investigaci\u00f3n Biom\u00e9dica de Occidente (CIBO), Centro M\u00e9dico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"ref_1","unstructured":"(2025, January 09). Cancer (IARC), T.I.A. for R. on Global Cancer Observatory. Available online: https:\/\/gco.iarc.fr\/."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"\u0141ukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., and Stanis\u0142awek, A. (2021). Breast Cancer\u2014Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies\u2014An Updated Review. Cancers, 13.","DOI":"10.3390\/cancers13174287"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Smolarz, B., Nowak, A.Z., and Romanowicz, H. (2022). Breast Cancer\u2014Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). Cancers, 14.","DOI":"10.3390\/cancers14102569"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1038\/cddis.2013.24","article-title":"A Meta-Analysis of Cancer Risk Associated with the TP53 Intron 3 Duplication Polymorphism (Rs17878362): Geographic and Tumor-Specific Effects","volume":"4","author":"Sagne","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-0716-0904-0_5","article-title":"Diagnosis and Treatment of Breast Cancer in the Precision Medicine Era","volume":"2204","author":"Yan","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13058-023-01636-1","article-title":"Modifiable Risk Factors in Women at High Risk of Breast Cancer: A Systematic Review","volume":"25","author":"Cohen","year":"2023","journal-title":"Breast Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10911-023-09540-2","article-title":"Molecular Characterization and Landscape of Breast Cancer Models from a Multi-Omics Perspective","volume":"28","author":"Ortiz","year":"2023","journal-title":"J. Mammary Gland. Biol. Neoplasia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41467-020-20496-3","article-title":"A Case-Only Study to Identify Genetic Modifiers of Breast Cancer Risk for BRCA1\/BRCA2 Mutation Carriers","volume":"12","author":"Coignard","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Nicolis, O., De Los Angeles, D., and Taramasco, C. (2024). A Contemporary Review of Breast Cancer Risk Factors and the Role of Artificial Intelligence. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1356014"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast Cancer: Pathogenesis and Treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e70404","DOI":"10.1002\/mco2.70404","article-title":"Breast Cancer: Molecular Pathogenesis and Targeted Therapy","volume":"6","author":"Samad","year":"2025","journal-title":"MedComm"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-024-02218-1","article-title":"The Roles of KRAS in Cancer Metabolism, Tumor Microenvironment and Clinical Therapy","volume":"24","author":"Ma","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41392-021-00780-4","article-title":"KRAS Mutation: From Undruggable to Druggable in Cancer","volume":"6","author":"Huang","year":"2021","journal-title":"Sig Transduct. Target. Ther."},{"key":"ref_14","first-page":"897","article-title":"KRAS Signaling Enriched Triple Negative Breast Cancer Is Associated with Favorable Tumor Immune Microenvironment and Better Survival","volume":"10","author":"Tokumaru","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41392-025-02473-8","article-title":"Targeting KRAS Mutations: Orchestrating Cancer Evolution and Therapeutic Challenges","volume":"10","author":"Choucair","year":"2025","journal-title":"Sig Transduct. Target. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1038\/emm.2014.99","article-title":"Activation of KRAS Promotes the Mesenchymal Features of Basal-Type Breast Cancer","volume":"47","author":"Kim","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"105150","DOI":"10.1016\/j.critrevonc.2026.105150","article-title":"KRAS Mutations Reshape the Immunosuppressive Tumor Microenvironment in Triple-Negative Breast Cancer: A Novel Perspective","volume":"219","author":"Lv","year":"2026","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.2741\/4879","article-title":"Beyond the Coding Genome: Non-Coding Mutations and Cancer","volume":"25","author":"Walavalkar","year":"2020","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Lange, M., Begolli, R., and Giakountis, A. (2021). Non-Coding Variants in Cancer: Mechanistic Insights and Clinical Potential for Personalized Medicine. Non-Coding RNA, 7.","DOI":"10.3390\/ncrna7030047"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Pe\u00f1a-Mart\u00ednez, E.G., and Rodr\u00edguez-Mart\u00ednez, J.A. (2024). Decoding Non-Coding Variants: Recent Approaches to Studying Their Role in Gene Regulation and Human Diseases. Front. Biosci.-Sch., 16.","DOI":"10.31083\/j.fbs1601004"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s43588-025-00878-7","article-title":"Predicting the Regulatory Impacts of Noncoding Variants on Gene Expression through Epigenomic Integration across Tissues and Single-Cell Landscapes","volume":"5","author":"Liu","year":"2025","journal-title":"Nat. Comput. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.trecan.2022.01.002","article-title":"Interplay between K-RAS and miRNAs","volume":"8","author":"Shui","year":"2022","journal-title":"Trends Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1158\/0008-5472.CAN-23-0296","article-title":"KRAS Hijacks the miRNA Regulatory Pathway in Cancer","volume":"83","author":"Bortoletto","year":"2023","journal-title":"Cancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12032-025-02873-4","article-title":"Genetic Variants in Oncogenic miRNA and 3\u2032 Untranslated Region of Tumor Suppressor Genes: Emerging Insight into Cancer Genetics","volume":"42","author":"Choudhary","year":"2025","journal-title":"Med. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.tcb.2022.10.001","article-title":"3\u2032UTR Heterogeneity and Cancer Progression","volume":"33","author":"Chan","year":"2023","journal-title":"Trends Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3103\/S0095452723050055","article-title":"Mechanisms of Intron-Mediated Enhancement of Expression: Welcome to the Hotel California","volume":"57","author":"Pydiura","year":"2023","journal-title":"Cytol. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"gkaf097","DOI":"10.1093\/nar\/gkaf097","article-title":"Sequence-Dependent and -Independent Effects of Intron-Mediated Enhancement Learned from Thousands of Random Introns","volume":"53","author":"Kowal","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"154147","DOI":"10.1016\/j.prp.2022.154147","article-title":"The Let-7 microRNA Binding Site Variant in KRAS as a Predictive Biomarker for Head and Neck Cancer Patients with Lymph Node Metastasis","volume":"239","author":"Ulusan","year":"2022","journal-title":"Pathol. Res. Pr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2217\/bmm-2019-0172","article-title":"KRAS SNPs Are Related to Colorectal Cancer Susceptibility and Survival in Chinese People","volume":"14","author":"Liu","year":"2020","journal-title":"Biomark. Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Rykova, E., Ershov, N., Damarov, I., and Merkulova, T. (2022). SNPs in 3\u2032UTR miRNA Target Sequences Associated with Individual Drug Susceptibility. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213725"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1039\/C9RA02816A","article-title":"The Micro RNA Hsa-miR-377-3p Inhibits Tumor Growth in Malignant Melanoma","volume":"9","author":"Yuan","year":"2019","journal-title":"RSC Adv."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gallegos-Arreola, M.P., Garibaldi-R\u00edos, A.F., Cruz-S\u00e1nchez, J.I., Figuera, L.E., Ronquillo-Carre\u00f3n, C.A., Rosales-Reynoso, M.A., G\u00f3mez-Meda, B.C., Carrillo-D\u00e1vila, I.A., Puebla-P\u00e9rez, A.M., and Montoya-Fuentes, H. (2023). Association of the Rs8720 and Rs12587 KRAS Gene Variants with Colorectal Cancer in a Mexican Population and Their Analysis In Silico. Cells, 12.","DOI":"10.3390\/cells12151941"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s12038-015-9567-8","article-title":"Regulatory Single Nucleotide Polymorphisms at the Beginning of Intron 2 of the Human KRAS Gene","volume":"40","author":"Antontseva","year":"2015","journal-title":"J. Biosci."},{"key":"ref_34","first-page":"333","article-title":"F\u00f3rmulas para el c\u00e1lculo de la muestra en investigaciones de salud","volume":"11","year":"2005","journal-title":"Salud Tabasco"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"D891","DOI":"10.1093\/nar\/gkad1049","article-title":"Ensembl 2024","volume":"52","author":"Harrison","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"D1276","DOI":"10.1093\/nar\/gkaa783","article-title":"miRNASNP-v3: A comprehensive database for SNPs and disease-related variations in miRNAs and miRNA targets","volume":"49","author":"Liu","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"D86","DOI":"10.1093\/nar\/gkt1028","article-title":"PolymiRTS Database 3.0: Linking Polymorphisms in microRNAs and Their Target Sites with Human Diseases and Biological Pathways","volume":"42","author":"Bhattacharya","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41588-023-01365-3","article-title":"Annotating and Prioritizing Human Non-Coding Variants with RegulomeDB v.2","volume":"55","author":"Dong","year":"2023","journal-title":"Nat. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gkr917","article-title":"HaploReg: A Resource for Exploring Chromatin States, Conservation, and Regulatory Motif Alterations within Sets of Genetically Linked Variants","volume":"40","author":"Ward","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"THE GTEX CONSORTIUM (2020). The GTEx Consortium Atlas of Genetic Regulatory Effects across Human Tissues. Science, 369, 1318\u20131330.","DOI":"10.1126\/science.aaz1776"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"24095","DOI":"10.1038\/srep24095","article-title":"SHEsisPlus, a Toolset for Genetic Studies on Polyploid Species","volume":"6","author":"Shen","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"BSR20204136","DOI":"10.1042\/BSR20204136","article-title":"Association Analysis of miRNA-Related Genetic Polymorphisms in miR-143\/145 and KRAS with Colorectal Cancer Susceptibility and Survival","volume":"41","author":"Wang","year":"2021","journal-title":"Biosci. Rep."},{"key":"ref_43","unstructured":"Al-Haddad1, R.H., Jasim1, H.M., and Saleh2, W.A. (2019). Association between KRAS Rs 712 G>T Polymorphism with the Incidence of Breast Tumors in Iraqi Women. Iraqi J. Biotechnol., 18, 55\u201361."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00383-025-06025-7","article-title":"RAS Gene Polymorphisms Confer the Risk of Neuroblastoma in Chinese Children from Jiangsu Province","volume":"41","author":"Xie","year":"2025","journal-title":"Pediatr. Surg. Int."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.18632\/aging.101855","article-title":"Association of KRAS and NRAS Gene Polymorphisms with Wilms Tumor Risk: A Four-Center Case-Control Study","volume":"11","author":"Fu","year":"2019","journal-title":"Aging"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Berisha, T.C., Cucu, M.G., Calot\u0103-Dobrescu, A., Sosoi, S.S., Ciurea, A.-M., Mehedin\u021beanu, A.M., Stovicek, P.O., Schenker, R.A., Mirea, C.S., and Cara, M.-L. (2026). Adverse Histopathological Features in Colorectal Cancer Associated with KRAS Rs61764370 SNP: A Preliminary Study. Biomedicines, 14.","DOI":"10.3390\/biomedicines14020319"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Yang, M., Xiao, X., Xing, X., Li, X., Xia, T., and Long, H. (2017). KRAS and VEGF Gene 3\u2032-UTR Single Nucleotide Polymorphisms Predicted Susceptibility in Colorectal Cancer. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0174140"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"8535","DOI":"10.1158\/0008-5472.CAN-08-2129","article-title":"A SNP in a Let-7 microRNA Complementary Site in the KRAS 3\u2032UTR Increases Non-Small Cell Lung Cancer Risk","volume":"68","author":"Chin","year":"2008","journal-title":"Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e2400017","DOI":"10.1111\/boc.202400017","article-title":"Association of 3\u2032UTR Variations of EGFR and KRAS Oncogenes with Clinical Parameters in Lung Cancer Tumours","volume":"116","author":"Bagci","year":"2024","journal-title":"Biol. Cell"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Hajibabaie, F., Abedpoor, N., Assareh, N., Tabatabaiefar, M.A., Shariati, L., and Zarrabi, A. (2022). The Importance of SNPs at miRNA Binding Sites as Biomarkers of Gastric and Colorectal Cancers: A Systematic Review. J. Pers. Med., 12.","DOI":"10.3390\/jpm12030456"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/1878-0261.12421","article-title":"Functional microRNA Binding Site Variants","volume":"13","author":"Yuan","year":"2019","journal-title":"Mol. Oncol."},{"key":"ref_52","first-page":"8","article-title":"The Promising Role of Let-7 Microrna in Colorectal Cancer: Practical Points for Clinicians","volume":"3","author":"Margetis","year":"2018","journal-title":"Clin. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"154","DOI":"10.7705\/biomedica.5957","article-title":"Caracterizaci\u00f3n Molecular de Pacientes Con C\u00e1ncer Colorrectal","volume":"42","author":"Palacio","year":"2022","journal-title":"Biomedica"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.4103\/ijo.IJO_3062_20","article-title":"Deciphering the Association of Intronic Single Nucleotide Polymorphisms of Crystallin Gene Family with Congenital Cataract","volume":"69","author":"Nair","year":"2021","journal-title":"Indian. J. Ophthalmol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"267","DOI":"10.31033\/ijrasb.8.2.36","article-title":"Intronic SNPs and Genetic Diseases: A Review","volume":"8","author":"Salih","year":"2021","journal-title":"Int. J. Res. Appl. Sci. Biotechnol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Eiholzer, R.A., Mehta, S., Kazantseva, M., Drummond, C.J., McKinney, C., Young, K., Slater, D., Morten, B.C., Avery-Kiejda, K.A., and Lasham, A. (2020). Intronic TP53 Polymorphisms Are Associated with Increased \u0394133TP53 Transcript, Immune Infiltration and Cancer Risk. Cancers, 12.","DOI":"10.3390\/cancers12092472"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCULATIONAHA.121.054083","article-title":"Variant Intronic Enhancer Controls SCN10A-Short Expression and Heart Conduction","volume":"144","author":"Man","year":"2021","journal-title":"Circulation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"104250","DOI":"10.1016\/j.critrevonc.2023.104250","article-title":"Deciphering the Role of KRAS Gene in Oncogenesis: Focus on Signaling Pathways, Genetic Alterations in 3\u2032UTR, KRAS Specific miRNAs and Therapeutic Interventions","volume":"194","author":"Chhichholiya","year":"2024","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2121993","DOI":"10.1155\/2022\/2121993","article-title":"The Regulatory Effects of MicroRNAs on Tumor Immunity","volume":"2022","author":"Lu","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3892\/mco.2025.2909","article-title":"Analysis of the Role of RNA Regulatory Networks in Cancer Treatment: Mechanisms, Applications and Future Prospects (Review)","volume":"23","author":"Ren","year":"2025","journal-title":"Mol. Clin. Oncol."},{"key":"ref_61","first-page":"e76477","article-title":"Evaluating the Role of KRAS and NRAS 3\u2032 Untranslated Region Polymorphisms in Susceptibility and Clinical Features of Laryngeal Squamous Cell Carcinoma","volume":"16","author":"Albahar","year":"2024","journal-title":"Cureus"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40164-019-0135-z","article-title":"NRAS and KRAS Polymorphisms Are Not Associated with Hepatoblastoma Susceptibility in Chinese Children","volume":"8","author":"Yang","year":"2019","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_63","first-page":"52","article-title":"Correlation between KRAS Gene Polymorphism and Non-small Cell Lung Cancer in Yunnan Han Population","volume":"44","author":"Liang","year":"2023","journal-title":"J. Kunming Med. Univ."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"579","DOI":"10.21037\/tp-20-359","article-title":"KRAS Gene Polymorphisms Are Associated with the Risk of Glioma: A Two-Center Case-Control Study","volume":"10","author":"Guan","year":"2021","journal-title":"Transl. Pediatr."},{"key":"ref_65","first-page":"4396","article-title":"Association between C-Myc and K-Ras Gene Polymorphisms and Non-Hodgkin Lymphoma","volume":"24","author":"Liu","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrg2361","article-title":"Linkage Disequilibrium\u2014Understanding the Evolutionary Past and Mapping the Medical Future","volume":"9","author":"Slatkin","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/321275","article-title":"Linkage Disequilibrium in Humans: Models and Data","volume":"69","author":"Pritchard","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2012.04.005","article-title":"Roles for microRNAs in Conferring Robustness to Biological Processes","volume":"149","author":"Ebert","year":"2012","journal-title":"Cell"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ccell.2020.03.013","article-title":"Targeting the MAPK Pathway in KRAS-Driven Tumors","volume":"37","author":"Drosten","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_70","first-page":"1344","article-title":"Hyperactivation of MAPK Induces Loss of ERalpha Expression in Breast Cancer Cells","volume":"15","author":"Oh","year":"2001","journal-title":"Mol. Endocrinol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/4\/948\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T12:33:09Z","timestamp":1776861189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/4\/948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":70,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["biomedicines14040948"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines14040948","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]}}}